Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg
Breast cancer is the most common female cancer in Europe, but its incidence and mortality are rapidly changing across Europe. The early termination of the women's health initiative (WHI) trial, after the detection of an increased breast cancer risk in hormone replacement therapy (HRT) users, was followed by strong declines of HRT use worldwide. We investigated whether the reduction of HRT sales affected breast cancer incidence in the Belgian province Limburg. All women registered in the Limburg Cancer Registry with a diagnosis of invasive breast cancer diagnosed between 1/1/1996 and 31/12/2005... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2009 |
Verlag/Hrsg.: |
SPRINGER
|
Schlagwörter: | Breast cancer / Hormonal therapy / Time trends / Epidemiology |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26529310 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/1942/10004 |